Norio Hotta - Concepedia

Author

Norio Hotta

Nagoya University ORCID

Also Known As

Hotta Norio, Hotta, Norio, N HOTTA, N Hotta, N. HOTTA, N. Hotta, NORIO HOTTA, Norio HOTTA, Norio Hotta, W.-X. Zhang

234

Publications

3.1K

Citations

H-Index

132

Concepts

All Affiliations

Nagoya University Chubu Rosai Hospital Chubu University The University of Texas Southwestern Medical Center University of Minnesota

About

Norio Hotta is an author at Nagoya University specializing in medicine, physiology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	33	1.4K
2	Health Sciences	12	16	494
3	Public Health	5	5	258
4	Education	1	1	31
5	Natural Sciences	1	1	28

Norio Hotta

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Jiro Nakamura, Koichi Kato, Yuichi Hamada, Diabetes Social SciencesOxidative StressMolecular PharmacologyDiabetic NeuropathyPkc Inhibition	1999	225
Long‐term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy Norio Hotta, Ryuzo Kawamori, Masakatsu Fukuda, Diabetic Medicine	2012	132
Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Akihiro Nomura, Yoshiharu Morita, Shoji Maruyama, PubMed	1997	110
Aldose Reductase Inhibition Prevents Glucose-induced Apoptosis in Cultured Bovine Retinal Microvascular Pericytes Keiji Naruse, Jun Nakamura, Yuichi Hamada, Experimental Eye Research Ocular DiseaseRetinaOphthalmologyBiochemistryExperimental Ophthalmology	2000	95
Arterial stiffness independently predicts cardiovascular events in an elderly community — Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) study Osamu Matsuoka, K. Otsuka, Shougo Murakami, Biomedicine & Pharmacotherapy AgingCardiovascular DiseaseGeriatricsLongevityCardiovascular Epidemiology	2005	92
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Yoji Hamada, Jiro Nakamura, Keiji Naruse, Diabetes Care	2000	90
The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis. Yoshiharu Morita, Akihiro Nomura, Y. Yuzawa, Journal of the American Society of Nephrology Glomerular DiseaseVasculitisRenal PathologyImmunologyPathology	1997	82
Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study Y. Goto, Norio Hotta, Y. Shigeta, Biomedicine & Pharmacotherapy Diabetes ManagementMedicineDiabetesDiabetic NeuropathyPharmacotherapy	1995	81
Effects of Long-term Enalapril Treatment on Persistent Microalbuminuria in Normotensive Type 2 Diabetic Patients: Results of a 4-year, Prospective, Randomized Study Takahisa Sano, Norio Hotta, Takahiko Kawamura, Diabetic Medicine	1996	77
The reduction and redistribution of plantar pressures using foot orthoses in diabetic patients H Kato, Toshio Takada, Takahiko Kawamura, Diabetes Research and Clinical Practice KinesiologyPlantar PressuresPhysiologyBiomechanicsDiabetes	1996	75

Page 1